Skip to content

2023 Year-End Financing, M&A, and Dealflow Report

Investment Trends in the Health & Nutrition Industry from 2023 and a look into 2024 opportunities.

NCN's 2023 Year-End Report + 2024 Opportunities

NCN releases a semi-annual Financing, M&A, and Dealflow Report providing both qualitative and quantitative analyses of the latest investment activities, deal flow, and industry trends.


The report dissects investment activities by segment and transaction type, utilizing the Global Financing and M&A Databases to scrutinize trends within 1,300+ Nutrition, Health, and Wellness deals annually. In addition to highlighting top deals and directional indicators, the report pinpoints opportunities in women’s health, weight management, longevity, and emerging alternative investment structures.


By offering market insights for active investors and strategic partners, NCN aims to facilitate financing, partnering, and asset sales for growing companies in the health and nutrition value chain.


Key insights from the 2023 year-end report include:

  • Decline in formerly popular tech-based segments
  • Growth of women’s health in the supplement industry
  • Overview of the 2023 Health and Nutrition investment landscape
  • Top 10 transactions of 2023
  • Industry opportunities and bright spots for 2024
  • Inclusion of 10 charts and tables showcasing up to 15 years of transaction history
  • Anticipation of fewer but more significant deals in the upcoming year
  • Investor readiness for active participation in 2024, emphasizing the importance of making investments for revenue growth.

— Reporting and analysis by Marc Brush, Mike Dovbish, Will Grubb

Priced at $495.00


Disclaimer: The information within this report has not been audited or verified, therefore accuracy is not guaranteed. All information contained in this summary or otherwise available from NCN is for general information purposes only and does not constitute investment advice nor the offer to sell nor the solicitation of an offer to purchase any securities in any jurisdiction. 


Still waiting for the rebound
While several categories are experiencing a surge in growth, the overall transaction activity has fallen by 28% in 2023. The industry is still waiting for a rebound.
Where does opportunity lie for 2024?​
Beverages were undoubtedly the industry leader in 2023, but where can we find opportunities in the upcoming year? While hydration and water brands still attract attention, technology-enabled brands might just be the key to the next big trend.​
Women's Health Hero
Women's health is growing in the supplement industry. This is an under-served market that is finally getting its due and trends suggest women's health will be a leading category in 2024.
Careful, Strategic, Disciplined
It's no secret, 2023 was one of the most disappointing years for entrepreneurs to raise capital. Our predictions for 2024 are that fewer transactions will be expected but bigger and stronger deals will be made.
Previous slide
Next slide

Sections within the 2023 Financing, M&A, and Dealflow Report

Table of Contents
  • Still Waiting for the Rebound
  •  2023 Overview
  • 2024 Outlook
  • Key Segment Analysis
  • Opportunity: Women’s Health, Weight Management, Longevity
  • Emerging: Alternative Investment Structures
  • 2023 Top Transaction Lists
  • 2023 Dealflow Analysis
  • 2023 Newsmakers
  • About NCN
  • 2023 Cornerstones & Sponsors
  • 2024 Meeting Schedule
  • Contact Us
Available Charts + Tables
  • Table 1: Total Transactions, 2018-2023
  • Sidebar: 10 Transactions that Caught Our Eye in 2023
  • Chart 1: Total Transactions, 2008-2023
  • Chart 2: Total Transactions by Quarter, 2017-2023
  • Sidebar: 5 Themes from Our Investment Network for 2024
  • Table 2: Financings by Key Segments, 2017-2023
  • Chart 3: Financings by Key Segments, 2015-2023
  • Table 3: M&A by Key Segments, 2017-2023
  • Chart 4: M&A by Key Segments, 2015-2023
  • Table 4: Total Financing Proceeds by Key Segments, 2019-2023
  • Table 5: Average Size of Financing by Key Segments, 2019-2023
  • Chart 5: Supplements, Total Transactions, 2016-2023
If you have questions around NCN’s 2023 year-end report, please contact Mike Dovbish at [email protected].